Oncogene - Table of Contents alert Volume 35 Issue 7

If you are unable to see the message below, click here to view.

Advertisement New! 3D cell culture for in vivo epigenetic experiments Diagenode offers a revolutionary solution to enhance your epigenetics research using 3D micro pattern cell culture plates Biologically relevant: Adherent cells form natural spheroids to measure of cell-to-cell interactions, not cell-to plastic Ready-to-use: No specific expertise required - just use right out of the box! Diverse: ChIP-seq, drug/inhibitor screening, toxicity assays, cell differentiation, and more Learn more TABLE OF CONTENTS Volume 35, Issue 7 (February 2016) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article.  Reviews Top Normal vs cancer thyroid stem cells: the road to transformation M Zane, E Scavo, V Catalano, M Bonanno, M Todaro, R De Maria and G Stassi Oncogene 2016 35: 805-815; advance online publication, May 11, 2015; 10.1038/onc.2015.138 Abstract | Full Text CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks F Guo, Y Wang, J Liu, S C Mok, F Xue and W Zhang Oncogene 2016 35: 816-826; advance online publication, May 11, 2015; 10.1038/onc.2015.139 Abstract | Full Text How do K-RAS-activated cells evade cellular defense mechanisms? OPEN Y-S Lee and S-C Bae Oncogene 2016 35: 827-832; advance online publication, May 11, 2015; 10.1038/onc.2015.153 Abstract | Full Text Original Articles Top The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models P L Garcia, A L Miller, K M Kreitzburg, L N Council, T L Gamblin, J D Christein, M J Heslin, J P Arnoletti, J H Richardson, D Chen, C A Hanna, S L Cramer, E S Yang, J Qi, J E Bradner and K J Yoon Oncogene 2016 35: 833-845; advance online publication, May 11, 2015; 10.1038/onc.2015.126 Abstract | Full Text Rho1–Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila X Ma, Y Chen, S Zhang, W Xu, Y Shao, Y Yang, W Li, M Li and L Xue Oncogene 2016 35: 846-855; advance online publication, May 11, 2015; 10.1038/onc.2015.137 Abstract | Full Text LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells Y M Whang, S I Park, I A Trenary, R A Egnatchik, J P Fessel, J M Kaufman, D P Carbone and J D Young Oncogene 2016 35: 856-866; advance online publication, June 29, 2015; 10.1038/onc.2015.140 Abstract | Full Text Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial–mesenchymal transition in non-small-cell lung cancer L Wang, H Yang, Z Lei, J Zhao, Y Chen, P Chen, C Li, Y Zeng, Z Liu, X Liu and H-T Zhang Oncogene 2016 35: 867-877; advance online publication, May 11, 2015; 10.1038/onc.2015.141 Abstract | Full Text Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib K Yonesaka, K Hirotani, H Kawakami, M Takeda, H Kaneda, K Sakai, I Okamoto, K Nishio, P A Jänne and K Nakagawa Oncogene 2016 35: 878-886; advance online publication, May 11, 2015; 10.1038/onc.2015.142 Abstract | Full Text hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells P Trono, F Di Modugno, R Circo, S Spada, A Di Benedetto, R Melchionna, B Palermo, S Matteoni, S Soddu, M Mottolese, R De Maria and P Nisticò Oncogene 2016 35: 887-896; advance online publication, May 11, 2015; 10.1038/onc.2015.143 Abstract | Full Text Targeting of nucleotide-binding proteins by HAMLET—a conserved tumor cell death mechanism J C S Ho, A Nadeem, A Rydström, M Puthia and C Svanborg Oncogene 2016 35: 897-907; advance online publication, June 1, 2015; 10.1038/onc.2015.144 Abstract | Full Text The nucleotide excision repair protein XPC is essential for bulky DNA adducts to promote interleukin-6 expression via the activation of p38-SAPK I Schreck, N Grico, I Hansjosten, C Marquardt, S Bormann, A Seidel, D L Kvietkova, D Pieniazek, D Segerbäck, S Diabaté, G T J van der Horst, B Oesch-Bartlomowicz, F Oesch and C Weiss Oncogene 2016 35: 908-918; advance online publication, May 18, 2015; 10.1038/onc.2015.145 Abstract | Full Text MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression D Pan, C Jiang, Z Ma, M Blonska, M J You and X Lin Oncogene 2016 35: 919-928; advance online publication, May 18, 2015; 10.1038/onc.2015.146 Abstract | Full Text Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein M R Tanas, S Ma, F O Jadaan, C K Y Ng, B Weigelt, J S Reis-Filho and B P Rubin Oncogene 2016 35: 929-938; advance online publication, May 11, 2015; 10.1038/onc.2015.148 Abstract | Full Text Advertisement Nature Genetics and Nature Reviews Cancer present: NUCLEAR REPROGRAMMING AND THE CANCER GENOME 2016 Sponsored by CapitalBio Corporation February 21-23, 2016 | La Jolla, CA, USA REGISTER NOW! Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.